COMMUNIQUÉS West-GlobeNewswire

Atara Biotherapeutics Announces Collaborator Presentation of Positive Phase 1 Clinical Results for a Mesothelin-Targeted CAR T Immunotherapy in Patients with Advanced Mesothelioma
31/03/2019
Memorial Sloan Kettering Cancer Center collaborators presented results that a regionally delivered mesothelin-targeted, autologous CAR T was well-tolerated and showed encouraging anti-tumor activity in combination with [...]
Novelion Therapeutics Observes World Lipodystrophy Day
31/03/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 31, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals [...]
Bio-on board of directors approves Draft Budget and IAS/IFRS Consolidated Financial Statement at 31 December 2018
30/03/2019
Consolidated revenues of 51 million Euro at 31 December 2018 compared to 11 million Euro at 31 December 2017; EBITDA of 42 million Euro at 31 December 2018 compared to 7 million Euro at 31 December 2017; EBIT of 40 [...]
Canada House Wellness Group Reports Third Quarter Fiscal Year 2019 Results
30/03/2019
49% Increase in Revenue Compared to the Same Period in the Prior Year NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 29, 2019 (GLOBE NEWSWIRE) -- Canada House [...]
MedMira Reports Second Quarter Results
30/03/2019
HALIFAX, Nova Scotia, March 29, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended January 31, 2019. Q2 FY2019 Financial Results Highlights Profit [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29/03/2019
CAMBRIDGE, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 29, 2019, that were previously [...]
Pacific Health Care Organization, Inc. Reports its 2018 Year-End Financial Results
29/03/2019
Newport Beach, CA, March 29, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its annual report on [...]
Vascepa® Granted Priority Review Status from Health Canada
29/03/2019
New Drug Submission (NDS) for Vascepa in Canada Anticipated to Be Filed in April 2019 by HLS Therapeutics, Under Agreement with Amarin BEDMINSTER, N.J., and DUBLIN, Ireland, March 29, 2019 (GLOBE NEWSWIRE) -- Amarin [...]
Synergy CHC Corp. Announces Fiscal 2018 Year End Results
29/03/2019
Westbrook, Maine, March 29, 2019 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December [...]
RavenQuest Completes Final Tranche of Non-Brokered Private Placement
29/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
Total number of shares and voting rights in Zealand Pharma at March 31, 2019
29/03/2019
Company announcement – No. 09 / 2019 Total number of shares and voting rights in Zealand Pharma at March 31, 2019 Copenhagen, March 29, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a Copenhagen-based [...]
Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors
29/03/2019
Jordan Kanfer to replace SongYi Zhang, J.D., who is stepping down BUFFALO, N.Y., March 29, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, [...]
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
29/03/2019
CHICAGO, March 29, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019
29/03/2019
Conference Call and Webcast to Be Held Tuesday, April 2, 2019 at 8:00 am ET / 1:00 pm BST LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company [...]
TG Therapeutics to Present Interim Data from the UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the Upcoming 2019 AACR Annual Meeting
29/03/2019
Abstract and full presentation will be publicly available Monday April 1, 2019 at 8:30am ET Company to host conference call on Monday, April 1, 2019 at 12:00pm (noon) ET, with Dr. Nathan Fowler of MD Anderson Cancer [...]
LipoMedix to Present New Clinical Data on Promitil® at American Association for Cancer Research (AACR) Annual Meeting 2019
29/03/2019
Givat Ram High-Tech Village, Jerusalem, March 29, 2019 (GLOBE NEWSWIRE) -- Lipomedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer [...]
ERYTECH Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
29/03/2019
LYON, France, March 29, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative by encapsulating therapeutic drug substances inside [...]
ERYTECH annonce le dépôt de son Document de Référence 2018 et de son Form 20-F 2018
29/03/2019
LYON, France, 29 mars 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments [...]
Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab
29/03/2019
Company Announcement Copenhagen, Denmark; March 29, 2019 – Following Genmab A/S’ (Nasdaq Copenhagen: GEN) Annual General Meeting held on March 29, 2019, the Company’s Board of Directors met to constitute itself. Mr. [...]

Pages